Arora, MD S, Setnik, PhD B, Drass, MD M, Hudson, MD JD, Clemmer, MS R, Meisner, PharmD P, Pixton, MS GC, Goli, MD V, Sommerville, MD KW. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain. J of Opioid Management [Internet]. 2014 Nov. 1 [cited 2024 Nov. 24];10(6):423-36. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/120